Dianjie Lin

744 total citations
28 papers, 510 citations indexed

About

Dianjie Lin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Dianjie Lin has authored 28 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Dianjie Lin's work include Pleural and Pulmonary Diseases (10 papers), Trauma Management and Diagnosis (3 papers) and Pneumothorax, Barotrauma, Emphysema (3 papers). Dianjie Lin is often cited by papers focused on Pleural and Pulmonary Diseases (10 papers), Trauma Management and Diagnosis (3 papers) and Pneumothorax, Barotrauma, Emphysema (3 papers). Dianjie Lin collaborates with scholars based in China, United Kingdom and United States. Dianjie Lin's co-authors include Yunyan Wan, Qinghua Liu, Aihua Wang, Wei Xiao, C. Jia, Liang Dong, Xi-Li Li, Yu Li, Hui Tian and Yongfeng Wang and has published in prestigious journals such as Oncotarget, The Lancet Respiratory Medicine and Thrombosis Research.

In The Last Decade

Dianjie Lin

28 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianjie Lin China 13 214 134 121 69 67 28 510
Xiaomeng Feng China 12 202 0.9× 245 1.8× 55 0.5× 158 2.3× 33 0.5× 21 552
Kun‐Yuan Chiu Taiwan 15 379 1.8× 260 1.9× 104 0.9× 118 1.7× 187 2.8× 99 804
Jiaqi Li China 14 205 1.0× 142 1.1× 127 1.0× 66 1.0× 58 0.9× 41 658
Hideko Ohama Japan 13 68 0.3× 121 0.9× 92 0.8× 47 0.7× 107 1.6× 53 659
Søren Astrup Jensen Denmark 13 109 0.5× 93 0.7× 393 3.2× 65 0.9× 62 0.9× 21 654
Kang‐Hyeon Choe South Korea 10 464 2.2× 182 1.4× 32 0.3× 78 1.1× 68 1.0× 15 733
Liping Xiong China 9 86 0.4× 159 1.2× 33 0.3× 38 0.6× 59 0.9× 29 528
Satoru Kakizaki Japan 18 115 0.5× 107 0.8× 139 1.1× 38 0.6× 142 2.1× 58 775
Meng Wan China 12 168 0.8× 144 1.1× 46 0.4× 85 1.2× 159 2.4× 32 443

Countries citing papers authored by Dianjie Lin

Since Specialization
Citations

This map shows the geographic impact of Dianjie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianjie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianjie Lin more than expected).

Fields of papers citing papers by Dianjie Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianjie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianjie Lin. The network helps show where Dianjie Lin may publish in the future.

Co-authorship network of co-authors of Dianjie Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dianjie Lin. A scholar is included among the top collaborators of Dianjie Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianjie Lin. Dianjie Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Nanshan, Rong Qiu, Jie Cao, et al.. (2025). Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet Respiratory Medicine. 13(5). 414–424. 9 indexed citations
2.
Wang, Jing, et al.. (2021). Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC. Genes & Genomics. 43(2). 105–114. 6 indexed citations
3.
Zhang, Haoran, et al.. (2021). Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer. Journal of Cancer Research and Clinical Oncology. 148(3). 685–695. 9 indexed citations
4.
Wan, Yunyan, Qinghua Liu, Ling Zhu, et al.. (2019). Safety and complications of medical thoracoscopy in the management of pleural diseases. BMC Pulmonary Medicine. 19(1). 125–125. 36 indexed citations
5.
Li, Dezhi, Li Xu, Dianjie Lin, et al.. (2018). Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome. Respiratory Medicine Case Reports. 25. 213–215. 12 indexed citations
6.
Liu, Qinghua, et al.. (2018). Erythromycin poudrage versus erythromycin slurry in the treatment of refractory spontaneous pneumothorax. Journal of Thoracic Disease. 10(2). 757–765. 1 indexed citations
7.
Wan, Yunyan, et al.. (2018). Berberine induces mitochondrial‑mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI‑H2452 cells. Oncology Reports. 40(6). 3603–3610. 26 indexed citations
8.
Ye, Hong, Qiufen Li, Maisa Kasanga, & Dianjie Lin. (2017). Bibliometric analysis of tuberculosis pleurisy based on web of science. Biomedical Research-tokyo. 28(7). 3322–3327. 3 indexed citations
9.
Liu, Qinghua & Dianjie Lin. (2017). Utility of medical thoracoscopy in diagnosis and treatment of hemothorax due to carcinoma: A case report. Journal of Cancer Research and Therapeutics. 16(4). 933–933. 2 indexed citations
10.
Chen, Juan, Haitao Yang, Li Zhu, et al.. (2016). Construction of protein interaction network involved in lung adenocarcinomas using a novel algorithm. Oncology Letters. 12(3). 1792–1800. 1 indexed citations
11.
Li, Bin, et al.. (2016). Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer. Oncotarget. 7(47). 77342–77347. 16 indexed citations
12.
Wang, Yongfeng, et al.. (2015). SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3. Cell Stress and Chaperones. 20(5). 805–810. 45 indexed citations
13.
Wan, Yunyan, et al.. (2014). Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma. Tumor Biology. 35(7). 6839–6845. 23 indexed citations
14.
Lin, Dianjie, et al.. (2014). Prognostic Role of Heart-type Fatty Acid Binding Protein in Pulmonary Embolism: a Meta-analysis. Thrombosis Research. 135(1). 20–25. 8 indexed citations
15.
Wan, Yunyan, et al.. (2013). Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. Journal of Cancer Research and Clinical Oncology. 139(12). 2117–2123. 68 indexed citations
16.
17.
Lin, Dianjie. (2011). EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy. Oncology Reports. 27(3). 880–90. 8 indexed citations
18.
Jia, C., Hui Tian, Wei Xiao, et al.. (2009). Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respiratory Medicine. 103(12). 1949–1953. 68 indexed citations
19.
Lin, Dianjie, Wei Xiao, C. Jia, et al.. (2009). Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. Respiratory Research. 10(1). 91–91. 34 indexed citations
20.
Lin, Dianjie, et al.. (2006). Thoracoscopy for diagnosis and management of refractory hepatic hydrothorax. Chinese Medical Journal. 119(5). 430–434. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026